Ugurlu, S. Et Al. 2017. Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever. ORPHANET JOURNAL OF RARE DISEASES , vol.12 .

Ugurlu, S., Hacioglu, A., Adibnia, Y., Hamuryudan, V., & Ozdogan, H., (2017). Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever. ORPHANET JOURNAL OF RARE DISEASES , vol.12.

Ugurlu, Serdal Et Al. "Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever," ORPHANET JOURNAL OF RARE DISEASES , vol.12, 2017

Ugurlu, Serdal Et Al. "Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever." ORPHANET JOURNAL OF RARE DISEASES , vol.12, 2017

Ugurlu, S. Et Al. (2017) . "Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever." ORPHANET JOURNAL OF RARE DISEASES , vol.12.

@article{article, author={Serdal Ugurlu Et Al. }, title={Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever}, journal={ORPHANET JOURNAL OF RARE DISEASES}, year=2017}